SCHEMBL20256804

SCHEMBL20256804

N#Cc1ccc2c(c1)nc(-c1ccccc1)c1cc(P(=O)(c3ccccc3)c3cc4c(-c5ccccc5)nc5cc(C#N)ccc5c4c4ccccc34)c3ccccc3c12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 3/20 0.40
KCNA5 P22460 2/20 0.38
KCNN4 O15554 1/20 0.38
ABCG2 Q9UNQ0 4/20 0.36
ABCB1 P08183 2/20 0.36
ADORA1 P30542 2/20 0.34
ALDH1A1 P00352 5/20 0.33
MEN1 O00255 4/20 0.33
KMT2A Q03164 4/20 0.33
CYP1A2 P05177 3/20 0.33
LMNA P02545 3/20 0.33
CA1 P00915 2/20 0.33
CA2 P00918 2/20 0.33
CYP3A4 P08684 2/20 0.33
CYP2C19 P33261 2/20 0.33
CLK4 Q9HAZ1 2/20 0.33
TSHR P16473 2/20 0.33
HSD17B10 Q99714 2/20 0.33
KDM4E B2RXH2 2/20 0.33
F2 P00734 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20249897 0.86 NUDT1 (0.40) ADORA2AALDH1A1MEN1KMT2ALMNA
SCHEMBL17035150 0.84 NUDT1 (0.40) ADORA2AALDH1A1MEN1KMT2ALMNA
SCHEMBL20249900 0.79 ALDH1A1 (0.39) ADORA2AKCNA5KCNN4ADORA1ALDH1A1
SCHEMBL20249899 0.78 NUDT1 (0.39) ADORA2AALDH1A1MEN1KMT2ALMNA
SCHEMBL20967904 0.76 TOP1 (0.48) ADORA2ARXFP1MAPT
SCHEMBL18200499 0.74 DHODH (0.37) ADORA2AADORA1ALDH1A1MEN1KMT2A
SCHEMBL23861211 0.73 CSF1R (0.35) ADORA2AKCNA5KCNN4ABCG2ABCB1
SCHEMBL20245381 0.72 MEN1 (0.40) ADORA2AABCG2ABCB1ALDH1A1MEN1
SCHEMBL20256065 0.72 MEN1 (0.40) ADORA2AKCNA5KCNN4ABCG2ABCB1
SCHEMBL19009761 0.72 TOP1 (0.38) ADORA2AALDH1A1MEN1KMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180166639-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180166639-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME RCC1, CCNA1, CTCF ADORA2A 1587/4885KCNA5 429/4885KCNN4 449/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.